MAST is active in 13 UK sites
216 PATIENTS ENROLLED
54 PATIENTS ENROLLED
MAST trials aim to define best practice in the use of anti-epileptic drugs for patients following a traumatic brain injury. MAST is comprised of two independent trials:
MAST-PROPHYLAXIS and MAST DURATION.
MAST-PROPHYLAXIS compares different anti-epileptic treatments in the prevention of seizures.
MAST-DURATION compares a short course and a long course of anti-epileptic treatment in the treatment of seizures.